drugset / Trial / NCT05369650

To Explore the Safety and Efficacy of Intravenous Infusion of Different Doses of Lidocaine in Patients

NCT05369650 ↗

Unknown 120 enrolled West China Hospital
RandomizedParallel-groupQuadruple-blindTreatment

Summary

All patients who met the inclusion criteria were randomly divided into four groups, 30 cases in each group, which were lidocaine group 1, lidocaine group 1.5, lidocaine group 2, and the placebo group In lidocaine group 1, lidocaine group 1.5, and lidocaine group 2, 1% lidocaine 1.5 mg/kg was intravenously infused with a micropump after anesthesia induction, and the infusion was completed within 10 minutes according to the ideal body weight, and then continued for 1% lidocaine was infused at 1 mg/kg.h, 1.5 mg/kg.h and 2 mg/kg.h respectively until the end of the operation. In the placebo group, the same volume of normal saline was used instead.

Timeline

Start
2019-07-27
Primary completion
2022-05-27
Completion
2022-09-27

Drugs

EvaluationDrugModalityDoseRoute
Subject Lidocaine Other / unclassified 1 mg/kg Intravenous
Subject Lidocaine Other / unclassified 1.5 mg/kg Intravenous
Subject Lidocaine Other / unclassified 2 mg/kg Intravenous

Indications